发布求助
文献互助 智能选刊 最新文献

Future cardiology最新文献

筛选
英文 中文
The role of chronic total occlusions in non-infarct-related arteries in acute coronary syndrome patients: a systematic review. 急性冠状动脉综合征患者非梗死相关动脉慢性全闭塞的作用：系统综述。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-10-09 DOI: 10.1080/14796678.2024.2406651
Hussein Sliman, Rim Kasem Ali Sliman, Paul Knaapen, Alex Nap, Jose Henriques, Niels Verouden, Bimmer EPM Claessen
{"title":"The role of chronic total occlusions in non-infarct-related arteries in acute coronary syndrome patients: a systematic review.","authors":"Hussein Sliman, Rim Kasem Ali Sliman, Paul Knaapen, Alex Nap, Jose Henriques, Niels Verouden, Bimmer EPM Claessen","doi":"10.1080/14796678.2024.2406651","DOIUrl":"10.1080/14796678.2024.2406651","url":null,"abstract":"<p><p><b>Aim:</b> This systematic review evaluated the impact of a chronic total occlusion (CTO) in a non-infarct-related artery (non-IRA) on clinical outcomes in acute coronary syndrome (ACS) patients and assessed the benefits of staged revascularization.<b>Methods:</b> We performed a comprehensive systematic review to provide further insight into the impact of a CTO in a non-IRA on clinical outcomes after ACS. Moreover, we review the currently available evidence on the clinical significance of staged revascularization for a CTO in a non-IRA patients with ACS and propose whether prophylactic CTO percutaneous coronary intervention (PCI) could improve outcomes in patients who subsequently develop an ACS.<b>Results:</b> Our search identified 999 studies, from which 30 were selected and ten were included in the analysis. The results showed a trend of higher all-cause mortality and major adverse cardiac event rates in the culprit-only-PCI group compared with the multivessel (MV)-PC I group in ST elevation myocardial infarction patients, with varying statistical significance across different outcomes.<b>Conclusion:</b> This review highlights the significant impact of non-IRA CTOs in ACS. Successful CTO revascularization may provide benefits, particularly in ST elevation myocardial infarction, but the optimal management approach remains uncertain. The presence of a non-IRA CTO, especially in cardiogenic shock, predicts worse outcomes. Further research is warranted to determine the effective strategies to improve survival.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":"20 10","pages":"581-590"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142389692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implantable loop recorder via subscapular approach in 2.7 kg neonate. 通过肩胛下入路为 2.7 千克新生儿植入循环记录器。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-10-16 DOI: 10.1080/14796678.2024.2406111
Ashley Wong, Daniel Cortez
{"title":"Implantable loop recorder via subscapular approach in 2.7 kg neonate.","authors":"Ashley Wong, Daniel Cortez","doi":"10.1080/14796678.2024.2406111","DOIUrl":"10.1080/14796678.2024.2406111","url":null,"abstract":"<p><p>Implantable loop records allow continuous heart rhythm monitoring with the ability to be stored and viewed remotely. The limited use in the pediatric population stems from the unknown indications of use and feasibility of implantation. We describe the case of a 2.7kg female with Long QT3. A loop recorder helped identify breakthrough tachycardia and helped her transition to the next stage of care. Placement was at the left subscapular region with no complications. Implantable loop recorder placement is achievable in a 2.7 kg patient at corrected gestational age 38 weeks for LQT3 syndrome monitoring and management.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"689-693"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hearts in the sky: understanding the cardiovascular implications of air travel. 天空中的心：了解航空旅行对心血管的影响。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-09-20 DOI: 10.1080/14796678.2024.2396257
Tavishi Katoch, Sravya Pinnamaneni, Raunak Medatwal, Fnu Anamika, Kanishk Aggarwal, Shreya Garg, Rohit Jain
{"title":"Hearts in the sky: understanding the cardiovascular implications of air travel.","authors":"Tavishi Katoch, Sravya Pinnamaneni, Raunak Medatwal, Fnu Anamika, Kanishk Aggarwal, Shreya Garg, Rohit Jain","doi":"10.1080/14796678.2024.2396257","DOIUrl":"10.1080/14796678.2024.2396257","url":null,"abstract":"<p><p>Air travel is widely regarded as the safest mode of transportation, with the United States leading in airline passengers. However, travelers with pre-existing heart conditions face acute cardiovascular risks. Flight pilots and cabin crew are particularly vulnerable to air travel's physiological changes, which can significantly impair their health and performance. Cabin pressure differences and reduced oxygen levels at cruising altitudes of 5000-8000 feet make air travel challenging for individuals with underlying cardiac and pulmonary problems. This, along with dry air, sleep deprivation, missed medication and prolonged sitting, can lead to physiological changes. In-flight and pre-flight stressors contribute to increased health issues, and studies show a rise in medical emergencies during flights. Prolonged exposure to the airplane environment can lead to various health issues for pilots and cabin crew. These changes include impaired judgment, cognitive function and discomfort in the sinuses and ears due to pressure differentials. Therefore, thorough medical screening, skilled instrument use and compliance with safety measures are essential to mitigate these risks. This article reviews the cardiac implications of air travel, discussing the underlying pathophysiology, associated risks and preventive measures to ensure safer flights for individuals with cardiovascular diseases.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"651-660"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142283914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proactive approaches in congestive heart failure: the significance of early goals of care discussion and palliative care. 充血性心力衰竭的积极治疗方法：早期护理目标讨论和姑息治疗的意义。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-09-30 DOI: 10.1080/14796678.2024.2404323
Bhupinder Singh, Meet A Patel, Shreya Garg, Vasu Gupta, Amishi Singla, Rohit Jain
{"title":"Proactive approaches in congestive heart failure: the significance of early goals of care discussion and palliative care.","authors":"Bhupinder Singh, Meet A Patel, Shreya Garg, Vasu Gupta, Amishi Singla, Rohit Jain","doi":"10.1080/14796678.2024.2404323","DOIUrl":"10.1080/14796678.2024.2404323","url":null,"abstract":"<p><p>Congestive Heart Failure (CHF) poses significant challenges to the healthcare system due to its high rates of morbidity and mortality as well as frequent readmissions. All of these factors contribute to increased healthcare delivery costs. Besides the burden on the healthcare system, CHF has far deeper effects on the patient in terms of psychological burden along with debilitating symptoms of dyspnea, all of which reduce quality of life. Prognostic awareness among patients about their disease along with initiating early goals of care discussion by those involved in the care (physicians, nurses, social worker and patient themselves) can help mitigate these challenges. Adopting a proactive approach to address patient preferences, values and end-of-life goals improves patient-centred care, enhances quality of life and reduces the strain on healthcare resources. In this narrative review, studies have been identified using PubMed search to shed knowledge on what is preventing the initiation of goals of care discussions. Some barriers include lack of knowledge about prognosis in both patients and caregivers, inexperience or discomfort in having those conversations and delaying it until CHF becomes too advanced.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":"20 11-12","pages":"661-668"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142498614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magic Touch sirolimus-coated balloon: animal and clinical evidence of a coronary sirolimus drug-coated balloon. Magic Touch 西罗莫司涂层球囊：冠状西罗莫司药物涂层球囊的动物和临床证据。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-08-06 DOI: 10.1080/14796678.2024.2345023
Bernardo Cortese, Sara Malakouti, Jacinthe Khater, Amit Munjal
{"title":"Magic Touch sirolimus-coated balloon: animal and clinical evidence of a coronary sirolimus drug-coated balloon.","authors":"Bernardo Cortese, Sara Malakouti, Jacinthe Khater, Amit Munjal","doi":"10.1080/14796678.2024.2345023","DOIUrl":"10.1080/14796678.2024.2345023","url":null,"abstract":"<p><p>The Magic Touch sirolimus-coated balloon (SCB) was recently introduced in Europe and features robust clinical technology different from other devices on the market. This device is able to deliver a sufficient sirolimus dose to the target segment to reduce neointimal proliferation with very little exposure downstream and no apparent adverse effects at sustained high drug concentrations. The SCB represents a promising novelty within the drug-coated balloon arena due to its mid-term efficacy and safety in the treatment of coronary artery disease, especially in <i>de novo</i> and small-vessel coronary lesions. The purpose of this article is to provide an up-to-date overview of the currently available animal and clinical trial results, as well as to highlight ongoing trials on the Magic Touch SCB.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"521-535"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11485756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impella™-assisted left main coronary artery intervention via aortofemoral bypass graft limb: a case report. Impella™辅助经主动脉旁路移植肢体进行左主干冠状动脉介入治疗：病例报告。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-05-28 DOI: 10.1080/14796678.2024.2342188
Abhinav Sood, Parul Gindra, Tanay Modi, Veera Pavan Kotaru
{"title":"Impella™-assisted left main coronary artery intervention via aortofemoral bypass graft limb: a case report.","authors":"Abhinav Sood, Parul Gindra, Tanay Modi, Veera Pavan Kotaru","doi":"10.1080/14796678.2024.2342188","DOIUrl":"10.1080/14796678.2024.2342188","url":null,"abstract":"<p><p>Aortofemoral graft limbs are a rarely used and understudied option for large-bore access for mechanical support due to a risk of downstream vascular events. Here we present a case of left main coronary artery percutaneous intervention utilizing an aortofemoral bypass graft limb for large-bore access for mechanical support with successful hemostasis utilizing a widely available suture-based closure device.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":"20 7-8","pages":"365-368"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of graft angiography with distal radial access: a retrospective cohort study. 使用桡动脉远端入路进行移植血管造影的结果：一项回顾性队列研究。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-15 DOI: 10.1080/14796678.2024.2373592
Hamid Iqbal, Fnu Manoj Kumar, Farrukh Mehmood, Fnu Kiran, Kajal Bai, Kajal Kumari, Fnu Suman, Deepak Kumar, Deepa Rani, Saroop Kumar Alies Rahol Rai, Jahanzeb Malik, Waheed Akhtar
{"title":"Outcomes of graft angiography with distal radial access: a retrospective cohort study.","authors":"Hamid Iqbal, Fnu Manoj Kumar, Farrukh Mehmood, Fnu Kiran, Kajal Bai, Kajal Kumari, Fnu Suman, Deepak Kumar, Deepa Rani, Saroop Kumar Alies Rahol Rai, Jahanzeb Malik, Waheed Akhtar","doi":"10.1080/14796678.2024.2373592","DOIUrl":"10.1080/14796678.2024.2373592","url":null,"abstract":"<p><p><b>Background:</b> This retrospective cohort study aimed to compare the outcomes of graft angiography using these two approaches.<b>Methods:</b> Medical records and angiographic data of adult patients who underwent graft angiography between January 2020 and December 2022 were analyzed.<b>Results:</b> The study included 452 patients in the distal radial access (DRA) group and 960 patients in the femoral access group. Angiographic characteristics showed a higher prevalence of triple vessel disease in the femoral access group (29.8% vs. 20.8%; <i>p</i> = 0.012). The DRA group had a procedural success rate of 93.0%, while the femoral access group had a higher success rate of 95.8%. The odds ratio was 0.66 (95% CI: 0.46-0.94), indicating lower odds of procedural success in the DRA group.<b>Conclusion:</b> Our study suggests that both DRA and femoral access are effective and safe approaches for graft angiography after coronary artery bypass surgery.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"479-484"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent developments in the management of resistant hypertension: focus on endothelin receptor antagonists. 耐药性高血压治疗的最新进展：聚焦内皮素受体拮抗剂。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-02 DOI: 10.1080/14796678.2024.2367390
Sayeh Heidari Nejad, Omar Azzam, Markus P Schlaich
{"title":"Recent developments in the management of resistant hypertension: focus on endothelin receptor antagonists.","authors":"Sayeh Heidari Nejad, Omar Azzam, Markus P Schlaich","doi":"10.1080/14796678.2024.2367390","DOIUrl":"10.1080/14796678.2024.2367390","url":null,"abstract":"<p><p>Resistant hypertension is characterized by the inability of guideline-recommended triple combination therapy to control blood pressure (BP) to target. It is associated with a significantly increased risk of adverse outcomes. Despite abundant preclinical evidence supporting the critical role of the endothelin pathway in resistant hypertension (RH), clinical implementation of endothelin antagonists for the treatment of hypertension was hindered by various factors. Recently, the novel dual endothelin-receptor antagonist aprocitentan was tested in individuals with resistant hypertension in the PRECISION trial and provided compelling evidence supporting both short and longer-term safety and clinically meaningful and sustained BP lowering efficacy. These findings resulted in the recent regulatory approval of aprocitentan by the FDA. Aprocitentan may be a particularly useful antihypertensive option for individuals with advanced age, chronic kidney disease, and albuminuria.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"435-445"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of SGLT2 inhibitors for anthracycline-induced cardiotoxicity: a meta-analysis in cancer patients. SGLT2 抑制剂对蒽环类药物引起的心脏毒性的疗效：一项针对癌症患者的荟萃分析。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-04 DOI: 10.1080/14796678.2024.2363673
Sana Mohsin, Misha Hasan, Zubaid Moazzam Sheikh, Fatima Mustafa, Vesna Tegeltija, Sarwan Kumar, Jai Kumar
{"title":"Efficacy of SGLT2 inhibitors for anthracycline-induced cardiotoxicity: a meta-analysis in cancer patients.","authors":"Sana Mohsin, Misha Hasan, Zubaid Moazzam Sheikh, Fatima Mustafa, Vesna Tegeltija, Sarwan Kumar, Jai Kumar","doi":"10.1080/14796678.2024.2363673","DOIUrl":"10.1080/14796678.2024.2363673","url":null,"abstract":"<p><p><b>Aim:</b> Sodium-glucose cotransporter-2 inhibitors (SGLT2i) lower anthracycline-induced cardiotoxicity.<b>Methods:</b> PubMed and Google Scholar were searched until September 2023 for studies regarding SGLT2i for treating anthracycline-induced cardiotoxicity. Overall mortality and cardiovascular events were considered. Using a random-effects model, data pooled RR and HR at a 95% confidence interval (CI).<b>Results:</b> 3 cohort studies were identified, analyzing 2817 patients. Results display a significant reduction in overall mortality [RR = 0.52 (0.33-0.82); <i>p</i> = 0.005; I<sup>2</sup>= 32%], HF hospitalization [RR = 0.20 (0.04-1.02); <i>p</i> = 0.05; I<sup>2</sup>= 0%] and no significant reduction in HF incidence [RR = 0.50 (0.20-1.16); <i>p</i> = 0.11, I<sup>2</sup>= 0%].<b>Conclusion:</b> SGLT2i mitigates mortality and hospitalization due to heart failure, improving cancer patient's chances of survival by undergoing anthracycline treatment.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"395-407"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457630/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141497797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intranasal etripamil for rapid treatment of paroxysmal supraventricular tachycardia. 鼻内注射依曲帕米快速治疗阵发性室上性心动过速。
IF 1.6
Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-05-20 DOI: 10.1080/14796678.2024.2342651
Peter Calvert, Dhiraj Gupta
{"title":"Intranasal etripamil for rapid treatment of paroxysmal supraventricular tachycardia.","authors":"Peter Calvert, Dhiraj Gupta","doi":"10.1080/14796678.2024.2342651","DOIUrl":"10.1080/14796678.2024.2342651","url":null,"abstract":"<p><p>Paroxysmal supraventricular tachycardia (PSVT) is a common arrhythmia that, although usually benign, can occur unpredictably, cause disabling symptoms and significantly impair quality of life. If spontaneous resolution does not occur, the only current self-treatment is for the patient to attempt vagal maneuvers, however, these are frequently unsuccessful. Hospital attendance is then required for intravenous therapy. Etripamil, an intranasal calcium channel blocker similar to verapamil, may be able to fill this therapeutic gap, allowing rapid self-treatment of PSVT at home. This narrative review discusses the latest evidence for etripamil and its potential role in future clinical practice.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"163-170"},"PeriodicalIF":1.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11216497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信